Essential tremor: predictors of disease progression in a clinical cohort

Por Putzke, J D, Whaley, N R, Baba, Y, Wszolek, Z K, Uitti, R J
Publicado em 2006

Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): A single entity?

Por Wider, C, Van Gerpen, J A., DeArmond, S, Shuster, E A., Dickson, D W., Wszolek, Z K.
Publicado em 2009

Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids

Por Van Gerpen, J A., Wider, C, Broderick, D F., Dickson, D W., Brown, L A., Wszolek, Z K.
Publicado em 2008

Clinical and genetic characterization of adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation

Por Konno, T., Yoshida, K., Mizuno, T., Kawarai, T., Tada, M., Nozaki, H., Ikeda, S.‐I., Nishizawa, M., Onodera, O., Wszolek, Z. K., Ikeuchi, T.
Publicado no Eur J Neurol (2016)

The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease.

Por Gasser, T, Müller-Myhsok, B, Supala, A, Zimmer, E, Wieditz, G, Wszolek, Z K, Vieregge, P, Bonifati, V, Oertel, W H
Publicado em 1996

A novel approach to dementia: High-resolution (1)H MRI of the human hippocampus performed at 21.1 T

Por Schweitzer, K.J., Foroutan, P., Dickson, D.W., Broderick, D.F., Klose, U., Berg, D., Wszolek, Z.K., Grant, S.C.
Publicado em 2010

Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS

Por DeJesus-Hernandez, M., Desaro, P., Johnston, A., Ross, O.A., Wszolek, Z.K., Ertekin-Taner, N., Graff-Radford, N.R., Rademakers, R., Boylan, K.
Publicado em 2011

Progression of dopaminergic dysfunction in a LRRK2 kindred: A multitracer PET study

Por Nandhagopal, R, Mak, E, Schulzer, M, McKenzie, J, McCormick, S, Sossi, V, Ruth, T J., Strongosky, A, Farrer, M J., Wszolek, Z K., Stoessl, A J.
Publicado em 2008

MEIS1 p.R272H IN FAMILIAL RESTLESS LEGS SYNDROME

Por Vilariño-Güell, C, Chai, H, Keeling, B H., Young, J E., Rajput, A, Lynch, T, Aasly, J O., Uitti, R J., Wszolek, Z K., Farrer, M J., Lin, S -C.
Publicado em 2009

Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN

Por Whitwell, J L., Jack, C R., Boeve, B F., Senjem, M L., Baker, M, Rademakers, R, Ivnik, R J., Knopman, D S., Wszolek, Z K., Petersen, R C., Josephs, K A.
Publicado em 2009

Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations

Por Whitwell, J L., Jack, C R., Boeve, B F., Senjem, M L., Baker, M, Ivnik, R J., Knopman, D S., Wszolek, Z K., Petersen, R C., Rademakers, R, Josephs, K A.
Publicado em 2009

MRS in presymptomatic MAPT mutation carriers: A potential biomarker for tau-mediated pathology

Por Kantarci, K., Boeve, B.F., Wszolek, Z.K., Rademakers, R., Whitwell, J.L., Baker, M.C., Senjem, M.L., Samikoglu, A.R., Knopman, D.S., Petersen, R.C., Jack, C.R.
Publicado em 2010

Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN

Por Whitwell, J.L., Weigand, S.D., Gunter, J.L., Boeve, B.F., Rademakers, R., Baker, M., Knopman, D.S., Wszolek, Z.K., Petersen, R.C., Jack, C.R., Josephs, K.A.
Publicado em 2011

Diagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia

Por Konno, T., Broderick, D.F., Mezaki, N., Isami, A., Kaneda, D., Tashiro, Y., Tokutake, T., Keegan, B.M., Woodruff, B.K., Miura, T., Nozaki, H., Nishizawa, M., Onodera, O., Wszolek, Z.K., Ikeuchi, T.
Publicado no AJNR Am J Neuroradiol (2017)

MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy

Por Vilariño-Güell, C., Soto-Ortolaza, A.I., Rajput, A., Mash, D.C., Papapetropoulos, S., Pahwa, R., Lyons, K.E., Uitti, R.J., Wszolek, Z.K., Dickson, D.W., Farrer, M.J., Ross, O.A.
Publicado em 2011

A family with parkinsonism, essential tremor, restless legs syndrome, and depression

Por Puschmann, A., Pfeiffer, R.F., Stoessl, A.J., Kuriakose, R., Lash, J.L., Searcy, J.A., Strongosky, A.J., Vilariño-Güell, C., Farrer, M.J., Ross, O.A., Dickson, D.W., Wszolek, Z.K.
Publicado em 2011

Association of the MAPT locus with Parkinson’s disease

Por Wider, C., Vilariño-Güell, C., Jasinska-Myga, B., Heckman, M. G., Soto-Ortolaza, A. I., Cobb, S. A., Aasly, J. O., Gibson, J. M., Lynch, T., Uitti, R. J., Wszolek, Z. K., Farrer, M. J., Ross, O. A.
Publicado em 2009

Altered functional connectivity in asymptomatic MAPT subjects: A comparison to bvFTD

Por Whitwell, J.L., Josephs, K.A., Avula, R., Tosakulwong, N., Weigand, S.D., Senjem, M.L., Vemuri, P., Jones, D.T., Gunter, J.L., Baker, M., Wszolek, Z.K., Knopman, D.S., Rademakers, R., Petersen, R.C., Boeve, B.F., Jack, C.R.
Publicado em 2011

AN INDEPENDENT REPLICATION OF PARK16 IN ASIAN SAMPLES

Por Vilariño-Güell, C., Ross, O.A., Aasly, J.O., White, L.R., Rajput, A., Rajput, A.H., Lynch, T., Krygowska-Wajs, A., Jasinska-Myga, B., Opala, G., Barcikowska, M., Lee, M.-C., Hentati, F., Uitti, R.J., Wszolek, Z.K., Farrer, M.J., Wu, R.-M.
Publicado em 2010

Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers

Por Aasly, J.O., Shi, M., Sossi, V., Stewart, T., Johansen, K.K., Wszolek, Z.K., Uitti, R.J., Hasegawa, K., Yokoyama, T., Zabetian, C.P., Kim, H.M., Leverenz, J.B., Ginghina, C., Armaly, J., Edwards, K.L., Snapinn, K.W., Stoessl, A.J., Zhang, J.
Publicado em 2012